MicroRNA profiling analysis revealed different cellular senescence mechanisms in human mesenchymal stem cells derived from different origin

Genomics

Volumn 109, Issue 3-4, 2017, Pages 147-157

  Meng, Xianhui ^a   Xue, Mengying ^a   Xu, Peng ^a   Hu, Feihu ^a   Sun, Bo ^a   Xiao, Zhongdang ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Cord blood; Mesenchymal stem cell; MicroRNA; Senescence; Umbilical cord

Indexed keywords

MICRORNA; MICRORNA 100 5P; MICRORNA 103A 3P; MICRORNA 106B 5P; MICRORNA 127 3P; MICRORNA 138 5P; MICRORNA 17 5P; MICRORNA 181A 5P; MICRORNA 18A 5P; MICRORNA 19A 3P; MICRORNA 19B 3P; MICRORNA 20A 5P; MICRORNA 21 5P; MICRORNA 22 3P; MICRORNA 224 3P; MICRORNA 23A 3P; MICRORNA 23B 3P; MICRORNA 24 3P; MICRORNA 27A 3P; MICRORNA 27B 3P; MICRORNA 29A 3P; MICRORNA 30A 5P; MICRORNA 30D 5P; MICRORNA 337 3P; MICRORNA 409 5P; MICRORNA 455 3P; MICRORNA 494; MICRORNA 574 3P; MICRORNA 99A 5P; UNCLASSIFIED DRUG; UNINDEXED DRUG; TRANSCRIPTOME;

ARTICLE; BIOPROCESS; CELL AGING; CELL CYCLE; CONTROLLED STUDY; CORD BLOOD MESENCHYMAL STEM CELL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; RNA ANALYSIS; RNA SEQUENCE; SEQUENCE ANALYSIS; UMBILICAL CORD MESENCHYMAL STEM CELL; CYTOLOGY; FETUS BLOOD; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; UMBILICAL CORD;

CELL AGING; FETAL BLOOD; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; TRANSCRIPTOME; UMBILICAL CORD;

EID: 85013130626     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2017.02.003     Document Type: Article

References (48)

1. Phinney, D.G., Prockop, D.J., Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views. Stem Cells 25:11 (2007), 2896–2902.
2. Munir, H., McGettrick, H.M., Mesenchymal stem cell therapy for autoimmune disease: risks and rewards. Stem Cells Dev. 24:18 (2015), 2091–2100.
3. Baksh, D., Yao, R., Tuan, R.S., Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:6 (2007), 1384–1392.
4. Kern, S., et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:5 (2006), 1294–1301.
5. Hsieh, J.Y., et al. Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One, 8(8), 2013, e72604.
6. Miura, T., Mattson, M.P., Rao, M.S., Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3:6 (2004), 333–343.
7. Campisi, J., di Fagagna, F.D.A., Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8:9 (2007), 729–740.
8. van Deursen, J.M., The role of senescent cells in ageing. Nature 509 (2014), 439–446.
9. Wagner, W., et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One, 3, 2008.
10. Stolzing, A., et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech. Ageing Dev. 129:3 (2008), 163–173.
11. Yu, K.R., et al. A p38 MAPK-mediated alteration of COX-2/PGE2 regulates immunomodulatory properties in human mesenchymal stem cell aging. PLoS One, 9(8), 2014, e102426.
12. Schellenberg, A., et al. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging-Us 3:9 (2011), 873–888.
13. Gatta, V., et al. Gene expression modifications in Wharton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturing. BMC Genomics, 14(1), 2013, 635.
14. Bellayr, I.H., et al. Gene markers of cellular aging in human multipotent stromal cells in culture. Curr. Stem Cell Res. Ther., 5, 2014, 59.
15. Ha, M., Kim, V.N., Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15:8 (2014), 509–524.
16. Shenoy, A., Blelloch, R.H., Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat. Rev. Mol. Cell Biol. 15 (2014), 565–576.
17. Okada, M., et al. Abrogation of age-induced microRNA-195 rejuvenates the senescent mesenchymal stem cells by reactivating telomerase. Stem Cells 34:1 (2016), 148–159.
18. Tome, M., et al. miR-335 correlates with senescence/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activity. Stem Cells 32:8 (2014), 2229–2244.
19. Yoo, J.K., et al. Discovery and characterization of miRNA during cellular senescence in bone marrow-derived human mesenchymal stem cells. Exp. Gerontol. 58 (2014), 139–145.
20. Meng, X., et al. Comparative analysis of microRNA expression in human mesenchymal stem cells from umbilical cord and cord blood. Genomics 107:4 (2016), 124–131.
21. Wang, L., et al. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26:1 (2010), 136–138.
22. Sun, B., et al. Comprehensive annotation of microRNA expression profiles. BMC Genet., 14(1), 2013, 1.
23. Huang da, W., Sherman, B.T., Lempicki, R.A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1 (2009), 1–13.
24. Huang da, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4:1 (2009), 44–57.
25. Merico, D., et al. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One, 5(11), 2010, e13984.
26. Dweep, H., Gretz, N., miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat. Methods, 12(8), 2015, 697.
27. Mendell, J.T., miRiad roles for the miR-17-92 cluster in development and disease. Cell 133 (2008), 217–222.
28. Hackl, M., et al. miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging Cell 9:2 (2010), 291–296.
29. Dhahbi, J.M., et al. Deep sequencing reveals novel micrornas and regulation of microRNA expression during cell senescence. PLoS One, 6, 2011.
30. Dellago, H., et al. High levels of oncomiR-21 contribute to the senescence-induced growth arrest in normal human cells and its knock-down increases the replicative lifespan. Aging Cell 12:3 (2013), 446–458.
31. Roeck, K., et al. miR-23a-3p causes cellular senescence by targeting hyaluronan synthase 2: possible implication for skin aging. J. Investig. Dermatol. 135:2 (2015), 369–377.
32. Wang, M., et al. Differential expression of oncogenic miRNAs in proliferating and senescent human fibroblasts. Mol. Cell. Biochem. 352:1–2 (2011), 271–279.
33. Liang, J., et al. MiR-138 induces renal carcinoma cell senescence by targeting EZH2 and is downregulated in human clear cell renal cell carcinoma. Oncogene Res. 21:2 (2013), 83–91.
34. Kim, S.Y., Lee, Y.-H., Bae, Y.-S., MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting α subunit of protein kinase CKII in human colorectal cancer cells. Biochem. Biophys. Res. Commun. 429:3 (2012), 173–179.
35. Xu, D., et al. miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 193:2 (2011), 409–424.
36. Martinez, I., et al. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc. Natl. Acad. Sci. 108:2 (2011), 522–527.
37. Li, G., et al. Alterations in microRNA expression in stress-induced cellular senescence. Mech. Ageing Dev. 130:11 (2009), 731–741.
38. Philipot, D., et al. p16INK4a and its regulator miR-24 link senescence and chondrocyte terminal differentiation-associated matrix remodelling in osteoarthritis. Arthritis Res. Ther., 16, 2014, R58.
39. Faraonio, R., et al. A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ. 19:4 (2012), 713–721.
40. Mancini, M., et al. MicroRNA-152 and-181a participate in human dermal fibroblasts senescence acting on cell adhesion and remodeling of the extracellular matrix. Aging-Us 4:11 (2012), 843–853.
41. Tazawa, H., et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. 104:39 (2007), 15472–15477.
42. Glud, M., et al. MicroRNA miR-125b induces senescence in human melanoma cells. Melanoma Res. 21:3 (2011), 253–256.
43. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136:2 (2009), 215–233.
44. Stern-Ginossar, N., et al. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol. 9:9 (2008), 1065–1073.
45. Smit, M.A., Peeper, D.S., Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY), 2(10), 2010, 735.
46. Cai, Z.G., et al. Aberrant expression of microRNAs involved in epithelial–mesenchymal transition of HT-29 cell line. Cell Biol. Int. 37:7 (2013), 669–674.
47. Lamouille, S., et al. Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs. Curr. Opin. Cell Biol. 25:2 (2013), 200–207.
48. Deschenes-Simard, X., et al. Cellular senescence and protein degradation: breaking down cancer. Cell Cycle 13:12 (2014), 1840–1858.